✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Halozyme Therapeutics Inc

Common Name
Halozyme Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
350
Ticker
HALO
Exchange
NASDAQ/NGS
Description
Halozyme Therapeutics Inc. is a biopharmaceutical company that specializes in developing and commercializing treatments focused on enhanced subcutaneous drug delivery. The company's proprietary techno...

Disclosures of Halozyme Therapeutics

Explore Halozyme Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Halozyme Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of Halozyme Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Halozyme Therapeutics's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
ESG Report
2024
Financial & Extra-Financial Disclosure
2024
10-K
2024
ESG Data Spreadsheet
2024
10-K
2023
ESG Report
2023
ESG Report
2022
10-K
2022
ESG Report
2021
10-K
2021
10-K
2020
10-K
2019
10-K
2018
10-K
2017
10-K
2016
10-K
2015
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?